Expert Opinion on Drug Safety

What to do with TNF failures
pp. 149-155(7)
Authors: Keystone Edward C; Kavanaugh Arthur

Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs
pp. 157-169(13)
Authors: Peng Sia; Duggan Anne

Benefits and risks assessment of simvastatin in familial hypercholesterolaemia
pp. 171-181(11)
Authors: Alonso Rodrigo; Mata Nelva; Mata Pedro

The development and application of imatinib
pp. 183-191(9)
Authors: Jones Robin L; Judson Ian R

Chemotherapy-induced oral mucositis: new approaches to prevention and management
pp. 193-200(8)
Authors: Wright Janice; Feld Ronald; Knox Jennifer

Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics
pp. 201-218(18)
Authors: Nolan David; Reiss Peter; Mallal Simon

Toxicity of the topoisomerase II inhibitors
pp. 219-234(16)
Author: Seiter Karen

The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis
pp. 235-239(5)
Authors: Starova Agron; Aly Raza

The safety and tolerability of botulinum toxins for the treatment of cervical dystonia
pp. 241-249(9)
Author: Brashear Allison

The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease
pp. 251-271(21)
Authors: Bonay Marcel; Bancal Catherine; Crestani Bruno

The safety of antidepressant use in pregnancy
pp. 273-284(12)
Authors: Kalra Sanjog; Born Leslie; Sarkar Moumita; Einarson Adrienne

Drug-induced aseptic meningitis
pp. 285-297(13)
Authors: Hopkins Susan; Jolles Stephen

Fluoroquinolones and tendon disorders
pp. 299-309(11)
Authors: Melhus Åsa

The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder
pp. 311-321(11)
Authors: Himpel Sunke; Banaschewski Tobias; Heise Cord-Alexander; Rothenberger Aribert

The safety of antiretroviral drugs in pregnancy
pp. 323-335(13)
Authors: Thorne Claire; Newell Marie-Louise

Selective serotonin re-uptake inhibitors and the risk of bleeding
pp. 337-344(8)
Authors: Weinrieb Robert M; Auriacombe Marc; Lynch Kevin G; Lewis James D

Teratogenicity of sodium valproate
pp. 345-353(9)
Authors: Alsdorf Rachel; Wyszynski Diego F

Interactions between herbal and conventional medicines
pp. 355-378(24)
Author: Williamson Elizabeth M